Seikagaku Corp (4548) Stock Price & News

4548:TYO

Seikagaku Corp

¥538.00

-0.19%

(-1.00) 1D

Nov 13, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4548...

Open

¥539

High

¥541

Low

¥534

Mkt. cap

30.57B

Avg. vol.

335.72K

Volume

124.70K

Dividend

4.65%

Quarterly dividend

¥6

Ex-dividend date

Mar 30, 2027

P/E ratio

1,239.60

52-wk high

¥820

52-wk low

¥523

EPS

¥0

Shares outstanding

56.40M

No. of employees

Open

¥539

High

¥541

Low

¥534

Mkt. cap

30.57B

Avg. vol.

335.72K

Volume

124.70K

Dividend

4.65%

Quarterly dividend

¥6

Ex-dividend date

Mar 30, 2027

P/E ratio

1,239.60

52-wk high

¥820

52-wk low

¥523

EPS

¥0

Shares outstanding

56.40M

No. of employees

Related stocks

4568

Daiichi Sankyo Co Ltd

¥2,852.50

-0.17%

4516

Nippon Shinyaku Co Ltd

¥3,396.00

-0.67%

4521

Kaken Pharmaceutical Co Ltd

¥3,825.00

-0.39%

4552

JCR Pharmaceuticals Co Ltd

¥499.00

+1.22%

News stories

From web sources and news partners

Longbridge

2 days ago

[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…

BigGo Finance

1 hour ago

Wall Street's Oldest Lesson: Sitting Out the Market Beats Almost Nothing

KuCoin

10 hours ago

AMD + Nvidia represent approximately 15% of the total S&P 50

24/7 Wall St.

2 hours ago

Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500

About Seikagaku Corp

CEO-

Employees1.14K

FoundedJun 2, 1947

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteseikagaku.co.jp

All values in JPY	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	9.02B	9.71B	8.83B	9.39B
Cost of goods sold	5.00B	4.97B	5.59B	5.59B
Cost of revenue	5.00B	4.97B	5.59B	5.59B
Research and development expenses	1.64B	2.34B	1.62B	1.72B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.46B	2.42B	2.57B	2.55B
Operating expense	4.11B	4.76B	4.18B	4.27B
Total operating expenses	9.10B	9.74B	9.78B	9.86B
Operating income	-79.00M	-24.00M	-943.00M	-472.00M
Other non operating income	21.00M	4.00M	5.00M	32.00M
EBT including unusual items	1.04B	110.00M	108.00M	495.00M
EBT excluding unusual items	413.00M	110.00M	-591.00M	-412.00M
Income tax expense	149.00M	-244.00M	119.00M	1.70B
Effective tax rate	14.34%	-221.82%	110.19%	344.44%
Other operating expenses	-	-	-	-
Net income	890.00M	354.00M	-11.00M	-1.21B
Net profit margin	9.86%	3.65%	-0.12%	-12.89%
Earnings per share	-	-	-	-
Interest and investment income	253.00M	52.00M	274.00M	41.00M
Interest expense	-6.00M	-1.00M	-1.00M	-2.00M
Net interest expenses	247.00M	51.00M	273.00M	39.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	419.75M	518.75M	-400.25M	70.75M
Gain or loss from assets sale	-	-	-	-

Ask anything